✦ LIBER ✦

Clinical efficacy of the selective endothelin A receptor antagonist, atrasentan, in patients with diabetes and chronic kidney disease (CKD)

✍ Scribed by Dennis L. Andress; Blai Coll; Yili Pritchett; John Brennan; Mark Molitch; Donald E. Kohan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The selective type A endothelin antagoni

✍ Andress, Dennis L.; de Zeeuw, Dick; Parving, Hans-Henrik 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 149 KB

193: Blood Pressure (BP) Control in Pati

✍ Naima Ogletree; Schawana Thaxton; Jerry Yee; Sandeep Soman 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 184 KB

The Chronic Kidney Disease Epidemiology

✍ E. G. Camargo; A. A. Soares; A. B. Detanico; L. S. Weinert; F. V. Veronese; E. C 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

19: The Effect of Baseline Estimated Glo

✍ Paul Audhya; Debra Scarlata; R. Kewalramani 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 203 KB

Effects of atorvastatin on renal functio

✍ Kenji Ueshima,Masato Kasahara,Daisuke Koya… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 188 KB

Safety and efficacy of protease-activate

✍ D. CAPODANNO; D. L. BHATT; S. GOTO; M. L. O’DONOGHUE; D. J. MOLITERNO; C. TAMBUR 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 308 KB